Related Experiment Video
Updated: Jan 23, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar
Masashi Kawami1, Risako Harada1, Takamichi Ojima1
1Department of Pharmaceutics and Therapeutics, Graduate School of Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.
Abstract:
Many drugs exert serious cytotoxic effects on pulmonary tissues. Although several reports have shown an association of epithelial-mesenchymal transition (EMT) with anticancer drug-induced lung injury, mechanisms of these effects are poorly understood. In the present study, we evaluated mechanisms of anticancer drug-induced EMT, with a focus on involvement of cell cycle arrest. We found that methotrexate (MTX) altered mRNA expression levels of many genes as determined by microarray analysis. Gene set enrichment analysis revealed that cell cycle arrest pathways may be associated with MTX-induced EMT. In addition, thymidine (THY) and nocodazole (NOC), which induce cell cycle arrest at S-phase and G2/M-phase, increased mRNA expression levels of α-smooth muscle actin (SMA), an EMT marker. Furthermore, α-SMA protein expression in cells arrested at S- and G2/M-phases by MTX and paclitaxel (PTX) was significantly higher than that in cells at G1. Notably, co-treatment of cells with THY or NOC and EMT-inducing anticancer drugs did not result in additional upregulation of α-SMA mRNA expression. These findings suggested that cell cycle arrest may be closely associated with anticancer drug-induced EMT in alveolar epithelial cells.
Insights
Anticancer drugs can cause lung injury by inducing epithelial-mesenchymal transition (EMT). This study reveals that cell cycle arrest, particularly at S- and G2/M-phases, is closely linked to MTX- and PTX-induced EMT in lung cells.
Area of Science:
- Pulmonary Pharmacology
- Cell Biology
- Drug Toxicology
Background:
- Anticancer drugs can cause significant lung tissue damage.
- Epithelial-mesenchymal transition (EMT) is implicated in drug-induced lung injury, but mechanisms remain unclear.
Purpose of the Study:
- To investigate the mechanisms underlying anticancer drug-induced EMT.
- To determine the role of cell cycle arrest in this process.
Main Methods:
- Microarray analysis to assess gene expression changes induced by methotrexate (MTX).
- Gene set enrichment analysis to identify associated pathways.
- Treatment with thymidine (THY) and nocodazole (NOC) to induce cell cycle arrest.
- Assessment of alpha-smooth muscle actin (α-SMA) expression at mRNA and protein levels.
Main Results:
- MTX altered mRNA expression, with cell cycle arrest pathways linked to EMT.
- THY and NOC increased α-SMA mRNA levels, indicating EMT.
- α-SMA protein levels were higher in cells arrested at S- and G2/M-phases by MTX and paclitaxel (PTX).
- Combined treatment with cell cycle arrest agents and EMT-inducing drugs did not further increase α-SMA mRNA.
Conclusions:
- Cell cycle arrest, specifically at S- and G2/M-phases, is closely associated with anticancer drug-induced EMT in alveolar epithelial cells.
- This suggests cell cycle modulation as a potential factor in drug-induced lung injury.
Related Concept Videos
What is the Cell Cycle?
What is the Cell Cycle?
Epithelial Tissues and Their Functions
Epithelial tissues provide the body's first line of protection from physical,...
Mesenchymal Stem Cells
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System

